← Leaderboards
Daniel Martin Ruscitto
University Of California, San Francisco
$633,387
Attributed
$1,900,162
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $671.4K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$1,900,162 · 1
By mechanism
R01$1,900,162 · 1
Top collaborators
- John Kurhanewicz3 shared
- Daniel B Vigneron3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Daniel B Vigneron$43,424,992
- Sabrina Miriam Ronen$18,398,578
- Jeremy William Gordon$6,602,958
- Peder Eric Zufall Larson$7,557,566
- Pavithra Viswanath$6,465,079
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseAdvanced Malignant NeoplasmAndrogensAnticancer ResearchBaseBiopsyCancer Clinical TrialCancer GenomicsCancer ImagingCancer PatientChemistryClinicClinical DataClinical InvestigationClinical ManagementClinical ResearchClinical TranslationClinical TrialsDeprivationDesignDiagnosisDoseEndotoxins2,4-Dinitrophenol
Grant awards (3)
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$600,901
R01 · FY2021 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$671,381
R01 · FY2020 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$627,880
R01 · FY2019 · CA